Table of Contents
Chapter 1. Global Nucleic Acid Amplification Testing Market Executive Summary
1.1. Global Nucleic Acid Amplification Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Application
1.3.3. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Nucleic Acid Amplification Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Nucleic Acid Amplification Testing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Rising Investment in Biotechnological Diagnostics
3.1.3. Technological Advancements in Diagnostic Methods
3.2. Market Challenges
3.2.1. Lack of Skilled Professionals
3.2.2. High Costs Associated with NAAT
3.3. Market Opportunities
3.3.1. Expansion in Emerging Markets
3.3.2. Growth in Point-of-Care Diagnostics
3.3.3. Increasing R&D Investments
Chapter 4. Global Nucleic Acid Amplification Testing Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Nucleic Acid Amplification Testing Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Polymerase Chain Reaction (PCR) Tests
5.2.2. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
5.2.3. Ligase Chain Reaction (LCR) Tests
Chapter 6. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Nucleic Acid Amplification Testing Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Infectious Disease Testing
6.2.2. Oncology Testing
6.2.3. Genetic & Mitochondrial Disease Testing
6.2.4. Others
Chapter 7. Global Nucleic Acid Amplification Testing Market Size & Forecasts by End-use 2022-2032
7.1. Segment Dashboard
7.2. Global Nucleic Acid Amplification Testing Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Central And Reference Laboratories
7.2.3. Others
Chapter 8. Global Nucleic Acid Amplification Testing Market Size & Forecasts by Region 2022-2032
8.1. North America Nucleic Acid Amplification Testing Market
8.1.1. U.S. Nucleic Acid Amplification Testing Market
8.1.1.1. Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End-use breakdown size & forecasts, 2022-2032
8.1.2. Canada Nucleic Acid Amplification Testing Market
8.2. Europe Nucleic Acid Amplification Testing Market
8.2.1. U.K. Nucleic Acid Amplification Testing Market
8.2.2. Germany Nucleic Acid Amplification Testing Market
8.2.3. France Nucleic Acid Amplification Testing Market
8.2.4. Spain Nucleic Acid Amplification Testing Market
8.2.5. Italy Nucleic Acid Amplification Testing Market
8.2.6. Rest of Europe Nucleic Acid Amplification Testing Market
8.3. Asia-Pacific Nucleic Acid Amplification Testing Market
8.3.1. China Nucleic Acid Amplification Testing Market
8.3.2. India Nucleic Acid Amplification Testing Market
8.3.3. Japan Nucleic Acid Amplification Testing Market
8.3.4. Australia Nucleic Acid Amplification Testing Market
8.3.5. South Korea Nucleic Acid Amplification Testing Market
8.3.6. Rest of Asia Pacific Nucleic Acid Amplification Testing Market
8.4. Latin America Nucleic Acid Amplification Testing Market
8.4.1. Brazil Nucleic Acid Amplification Testing Market
8.4.2. Mexico Nucleic Acid Amplification Testing Market
8.4.3. Rest of Latin America Nucleic Acid Amplification Testing Market
8.5. Middle East & Africa Nucleic Acid Amplification Testing Market
8.5.1. Saudi Arabia Nucleic Acid Amplification Testing Market
8.5.2. South Africa Nucleic Acid Amplification Testing Market
8.5.3. Rest of Middle East & Africa Nucleic Acid Amplification Testing Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Becton, Dickinson and Company
9.3.3. Danaher Corporation
9.3.4. Abbott Laboratories
9.3.5. Illumina, Inc.
9.3.6. Siemens Healthineers
9.3.7. bioMerieux SA
9.3.8. Novartis AG
9.3.9. Bio-Rad Laboratories, Inc.
9.3.10. Seegene Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes